AAAAAA

   
Results: 1-9 |
Results: 9
Structure-activity analysis of truncated orexin-A analogues at the orexin-1 receptor
Authors: Darker, JG Porter, RA Eggleston, DS Smart, D Brough, SJ Sabido-David, C Jerman, JC
Citation: Jg. Darker et al., Structure-activity analysis of truncated orexin-A analogues at the orexin-1 receptor, BIOORG MED, 11(5), 2001, pp. 737-740
1,3-Biarylureas as selective non-peptide antagonists of the orexin-1 receptor
Authors: Porter, RA Chan, WN Coulton, S Johns, A Hadley, MS Widdowson, K Jerman, JC Brough, SJ Coldwell, M Smart, D Jewitt, F Jeffrey, P Austin, N
Citation: Ra. Porter et al., 1,3-Biarylureas as selective non-peptide antagonists of the orexin-1 receptor, BIOORG MED, 11(14), 2001, pp. 1907-1910
Characterisation using FLIPR of human vanilloid VR1 receptor pharmacology
Authors: Smart, D Jerman, JC Gunthorpe, MJ Brough, SJ Ranson, J Cairns, W Hayes, PD Randall, AD Davis, JB
Citation: D. Smart et al., Characterisation using FLIPR of human vanilloid VR1 receptor pharmacology, EUR J PHARM, 417(1-2), 2001, pp. 51-58
Pharmacological characterisation of human 5-HT2 receptor subtypes
Authors: Jerman, JC Brough, SJ Gager, T Wood, M Coldwell, MC Smart, D Middlemiss, DN
Citation: Jc. Jerman et al., Pharmacological characterisation of human 5-HT2 receptor subtypes, EUR J PHARM, 414(1), 2001, pp. 23-30
SB-334867-A: the first selective orexin-1 receptor antagonist
Authors: Smart, D Sabido-David, C Brough, SJ Jewitt, F Johns, A Porter, RA Jerman, JC
Citation: D. Smart et al., SB-334867-A: the first selective orexin-1 receptor antagonist, BR J PHARM, 132(6), 2001, pp. 1179-1182
Characterisation of an endogenous bombesin receptor in CHO/DG44 cells
Authors: Brough, SJ Jerman, JC Jewitt, F Smart, D
Citation: Sj. Brough et al., Characterisation of an endogenous bombesin receptor in CHO/DG44 cells, EUR J PHARM, 409(3), 2000, pp. 259-263
Characterization using FLIPR of rat vanilloid receptor (rVR1) pharmacology
Authors: Jerman, JC Brough, SJ Prinjha, R Harries, MH Davis, JB Smart, D
Citation: Jc. Jerman et al., Characterization using FLIPR of rat vanilloid receptor (rVR1) pharmacology, BR J PHARM, 130(4), 2000, pp. 916-922
The hypocretins are weak agonists at recombinant human orexin-1 and orexin-2 receptors
Authors: Smart, D Jerman, JC Brough, SJ Neville, WA Jewitt, F Porter, RA
Citation: D. Smart et al., The hypocretins are weak agonists at recombinant human orexin-1 and orexin-2 receptors, BR J PHARM, 129(7), 2000, pp. 1289-1291
Characterization of recombinant human orexin receptor pharmacology in a Chinese hamster ovary cell-line using FLIPR
Authors: Smart, D Jerman, JC Brough, SJ Rushton, SL Murdock, PR Jewitt, F Elshourbagy, NA Ellis, CE Middlemiss, DN Brown, F
Citation: D. Smart et al., Characterization of recombinant human orexin receptor pharmacology in a Chinese hamster ovary cell-line using FLIPR, BR J PHARM, 128(1), 1999, pp. 1-3
Risultati: 1-9 |